日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AML

多选择性 RAS(ON) 抑制剂靶向致癌 RAS,并克服急性髓系白血病 (AML) 中 RAS 介导的对 FLT3 抑制剂和 BCL2 抑制剂的耐药性。

Popescu, Bogdan; Jones, Matthew F; Piao, Madison; Tran, Elaine; Koh, Andrew; Lomeli, Isabelle; Peretz, Cheryl A C; Murad, Natalia; Abelson, Sydney; Morales, Carolina; Rivera, Jose M; Batingana, Alexa Rane; D'Souza, Jeevitha; Pikman, Yana; Cheng, Michael L; Logan, Aaron C; Huang, Benjamin J; Stieglitz, Elliot; Smith, Catherine C

Clinical outcomes of older patients with NPM1-mutated or KMT2A-rearranged AML before menin inhibitors: a Beat AML report

在接受menin抑制剂治疗前,NPM1突变或KMT2A重排的AML老年患者的临床结局:Beat AML报告

Zeidner, Joshua F; Jain, Jayanshu; Welkie, Rina Li; Huang, Ying; Swords, Ronan T; Traer, Elie; Stein, Eytan M; Lin, Tara L; Madanat, Yazan F; Collins, Robert H; Baer, Maria R; Duong, Vu H; Blum, William G; Arellano, Martha L; Stock, Wendy; Odenike, Olatoyosi; Olin, Rebecca L; Smith, Catherine C; Foran, James M; Schiller, Gary J; Curran, Emily K; Handa, Shivani; Heerema, Nyla A; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja G; Rosenberg, Leonard; Druker, Brian J; Levine, Ross L; Burd, Amy; Yocum, Ashley O; Mims, Alice S; Byrd, John C; Borate, Uma

Reevaluating the Imiquimod Model: A Barrier to Translational Progress in Psoriasis

重新评估咪喹莫特模型:银屑病转化医学进展的障碍

Smith, Catherine C; Zwerner, Ian M; Gudjonsson, Johann E; Ward, Nicole L

Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial

对60岁及以上新诊断急性髓系白血病患者进行分子特征分析:来自Beat AML临床试验的报告

Hoff, Fieke W; Huang, Ying; Welkie, Rina Li; Swords, Ronan T; Traer, Elie; Stein, Eytan M; Lin, Tara L; Patel, Prapti A; Collins, Robert H Jr; Baer, Maria R; Duong, Vu H; Blum, William G; Arellano, Martha L; Stock, Wendy; Odenike, Olatoyosi; Redner, Robert L; Kovacsovics, Tibor; Deininger, Michael W; Zeidner, Joshua F; Olin, Rebecca L; Smith, Catherine C; Foran, James M; Schiller, Gary J; Curran, Emily K; Koenig, Kristin L; Heerema, Nyla A; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja G; Rosenberg, Leonard; Druker, Brian J; Levine, Ross L; Burd, Amy; Yocum, Ashley O; Borate, Uma M; Mims, Alice S; Byrd, John C; Madanat, Yazan F

Sphingosine-1-phosphate receptor modulators resensitize FLT3-ITD acute myeloid leukemia cells with NRAS mutations to FLT3 inhibitors

鞘氨醇-1-磷酸受体调节剂可使携带NRAS突变的FLT3-ITD急性髓系白血病细胞对FLT3抑制剂重新敏感

Chatterjee, Aditi; Mustafa Ali, Moaath K; Bailey, Christopher M; Liu, Yuchen; Small, Donald; Smith, Catherine C; Traer, Elie; Wang, Yin; Silvestri, Giovannino; Baer, Maria R

SNACS: a tool for demultiplexing single-cell DNA sequencing data

SNACS:一种用于单细胞DNA测序数据解复用的工具

Kennedy, Vanessa E; Roy, Ritu; Peretz, Cheryl A C; Koh, Andrew; Tran, Elaine; Smith, Catherine C; Olshen, Adam B

In vivo validation of the palmitoylation cycle as a therapeutic target in NRAS-mutant cancer.

体内验证棕榈酰化循环作为 NRAS 突变癌症的治疗靶点

Decker Matthew, Huang Benjamin J, Ware Timothy, Boone Christopher, Tang Michelle, Ybarra Julia, Ballapuram Aishwarya C, Taran Katrine A, Chen Pan-Yu, Amendáriz Marcos, Leung Camille J, Harris Max, Tjoa Karensa, Hongo Henry, Abelson Sydney, Rivera Jose, Ngo Nhi, Herbst Dylan M, Suciu Radu M, Guijas Carlos, Sedighi Kimia, Andalis Taylor, Roche Elysia, Xie Boer, Liu Yunlong, Smith Catherine C, Stieglitz Elliot, Niphakis Micah J, Cravatt Benjamin F, Shannon Kevin

Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid Leukemia.

多选择性 RAS(ON) 抑制靶向致癌 RAS 突变,克服急性髓系白血病中 RAS/MAPK 介导的对 FLT3 和 BCL2 抑制剂的耐药性

Popescu Bogdan, Jones Matthew F, Piao Madison, Tran Elaine, Koh Andrew, Lomeli Isabelle, Peretz Cheryl A C, Murad Natalia, Abelson Sydney, Morales Carolina, Rivera Jose M, Pikman Yana, Cheng Michael L, Logan Aaron C, Stieglitz Elliot, Smith Catherine C

LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia

LNK/SH2B3作为幼年型骨髓单核细胞白血病的新型驱动基因

Wintering, Astrid; Hecht, Anna; Meyer, Julia; Wong, Eric B; Hübner, Juwita; Abelson, Sydney; Feldman, Kira; Kennedy, Vanessa E; Peretz, Cheryl A C; French, Deborah L; Maguire, Jean Ann; Jobaliya, Chintan; Vasquez, Marta Rojas; Desai, Sunil; Dulman, Robin; Nemecek, Eneida; Haines, Hilary; Hammad, Mahmoud; El Haddad, Alaa; Kogan, Scott C; Abdullaev, Zied; Chehab, Farid F; Tasian, Sarah K; Smith, Catherine C; Loh, Mignon L; Stieglitz, Elliot

Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy

Beat-AML 2024 ELN 针对接受低强度治疗的新诊断 AML 老年患者进行了风险分层优化

Hoff, Fieke W; Blum, William G; Huang, Ying; Welkie, Rina Li; Swords, Ronan T; Traer, Elie; Stein, Eytan M; Lin, Tara L; Archer, Kellie J; Patel, Prapti A; Collins, Robert H; Baer, Maria R; Duong, Vu H; Arellano, Martha L; Stock, Wendy; Odenike, Olatoyosi; Redner, Robert L; Kovacsovics, Tibor; Deininger, Michael W; Zeidner, Joshua F; Olin, Rebecca L; Smith, Catherine C; Foran, James M; Schiller, Gary J; Curran, Emily K; Koenig, Kristin L; Heerema, Nyla A; Chen, Timothy; Martycz, Molly; Stefanos, Mona; Marcus, Sonja G; Rosenberg, Leonard; Druker, Brian J; Levine, Ross L; Burd, Amy; Yocum, Ashley O; Borate, Uma M; Mims, Alice S; Byrd, John C; Madanat, Yazan F